Abiopharma

🔍 JOHNSON KIRK L. (Executive)

Company: CONOCOPHILLIPS (COP)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 37,930 shares of Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | Expires: 2031-09-01 | equity_swap_involved: false | shares_owned_after: 37,930.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The stock units represent ConocoPhillips common stock on a 1-for-1 basis.
• F2: The stock units grant settles 5 years from date of grant, subject to earlier or partial settlement upon termination of employment due to layoff, death or disability, or a change in control.